Skip to content

Jennifer Hard

Erinoakkids Centre for Treatment and Development/Speech Language Pathologist

2024 Salary — last year on the list

$102,313

Total compensation $102,519, including $206 in taxable benefits.

Source: Ontario’s Public Sector Salary Disclosure — names paid $100,000 or more that year. How we build this · Report an error on this page

At a Glance
2024

Employer Rank

#99

Erinoakkids Centre for Treatment and Development

Years on List

1

2024–2024

Peak Salary

$102,313

2024

Full 2024 roster at Erinoakkids Centre for Treatment and Development →·See where $102,313 ranks →

Full History
2024–2024

Full salary history, by year
YearPositionSalary
2024Speech Language PathologistErinoakkids Centre For Treatment And Development$102,313Benefits $206Total $102,519

Take-Home Pay
(After Tax) · 2024 estimate

Jennifer Hard was paid $102,313 in 2024; after income tax, CPP and EI that is roughly $75,449, an effective income-tax rate of about 21.3%. Within Erinoakkids Centre for Treatment and Development, Jennifer Hard's total compensation of $102,519 was the #99 of 124, against a median salary of $108,325. This is Jennifer Hard's first appearance on the Sunshine List. Members of OMERS, OTPP, HOOPP or OPTrust typically take home another 7–10% less after pension contributions, which this estimate leaves out.

Estimated net pay
~$75,449
Effective income-tax rate (excl. CPP/EI)
~21.3%
CPP + EI contributions
~$5,105
All-in deduction rate (incl. CPP/EI)
~26.3%
vs. 2024 Speech Language Pathologist median
−9%

Where does $102,313 rank on the Sunshine List? →

Estimate only: 2024 federal and Ontario rates, basic personal amounts, Canada employment amount and CPP/EI credits; single, employment income only, salary treated as full-year income. Ignores pension contributions (OMERS, HOOPP, OTPP, OPTrust and similar plans lower actual take-home), union dues, RRSPs and benefits.

Also at Erinoakkids Centre for Treatment and Development
2024

View all 124 employees at Erinoakkids Centre for Treatment and Development (2024) →